A 66-year-old Southeast Asian male with medical history of hypertension, dyslipidemia, and diabetes developed dyspnea and was admitted to our hospital. He was diagnosed as acute myocardial infarction. The coronary angiography (CAG) revealed 75% stenosis in the proximal right coronary artery (RCA) and total occlusion of the distal RCA, and 90% stenosis in the proximal left anterior descending artery (LAD). The patient underwent percutaneous coronary intervention (PCI) with drug-eluting stent placement in the proximal LAD. Following PCI, the patient received dual antiplatelet therapy (DAPT) with aspirin and prasugrel. On day-14 of hospitalization, the patient suddenly developed hypotension and hypoxemia. Emergency CAG revealed subacute stent thrombosis in the proximal LAD and total occlusion of the proximal RCA. The patient underwent thrombus aspiration and the balloon dilatation. We switched the treatment of prasugrel to ticagrelor. After the DAPT with aspirin and ticagrelor no additional stenosis events were occurred. On day-49, the patient was discharged our hospital and went back to his country. The approved prasugrel loading and maintenance doses in Japan are respectively 20 mg/day and 3.75 mg/day, which are approximately 1/3 of other countries (60 mg/day loading and 10 mg/day maintenance) including China and South Korea. Therefore, treatment of prasugrel for foreign visitors may have the residual thrombosis risk and the dose adjustment after they return to home country. In contrast, ticagrelor dose in Japan is the same as other countries. Thus, it is necessary to consider the drug dosage and availability in other countries when the antiplatelet therapy is required.
View full abstract